Variantyx is an award-winning, technology-driven molecular diagnostics lab that offers innovative solutions in the genetic disorders, reproductive health, and precision oncology markets.

Its proprietary whole genome analysis platform provides unparalleled diagnostic capabilities, enhances personalized treatment recommendations, shortens the time to diagnosis, and reduces healthcare costs.The company offers a wide variety of test options, ranging from targeted to comprehensive analyses.

Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes.

All tests are performed on a whole genome platform.

This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic.

No additional sample or sequencing is required.